Daniel Butler MD

Announcing: The Geriatric Dermatology Society geriderm.org Thanks to leadership from medical student lead Shreya Sreekantaswamy from @UofUMedicine We hope this serves as a collaborative platform for research, clinical, educational advancement. #dermtwitter

Aging is something we all have in common We talked to aging skin expert @danielbutlermd about the pathophysiological changes to our skin and #immunesystem and how that affects #eczema Listen to the #podcast: nationaleczema.org/blog/podcast-a… #GetEczemaWise #atopicdermatitis #inflammaging

@itchdoctor Completely agree. Well said.

Optimism for science outside of academia is greater than it has ever been in my lifetime...pessimism for science inside academia is also greater than it has ever been. Those who can resolve this tension with out-of-the-box thinking will be astronomically successful.

Test Your Knowledge, Team Trivia Starts Tomorrow! Join us for an interactive symposium on IL-13 inhibitors in #atopicdermatitis, with @nationaleczema. Compete in real-time case discussions & expert panels, @drshawnkwatra and @DanielButlerMD bit.ly/4gHsadi

Menopause and Eczema Menopause is an excellent example of how age influences the skin via multiple systems. Thanks to the National Eczema Association for highlighting this critical population. nationaleczema.org/blog/menopause…

Join us tomorrow. Updates on the current state of "aging skin" clinical care and research with clinical cases. Send me a message if interested.

I was thrilled to join PALTtalk with Caring to discuss an important, yet often overlooked issue: chronic itch in older adults. It's a condition that deserves more attention, and I’m excited to help shed light on it. Listen now: paltmed.org/podcast

BIG NEWS! The Allen Discovery Center for Neuroimmune Interactions with @CellSymposia will co-host the next Neuro-immune axis symposium on September 7-9, 2025 in NYC! Keynotes include @NobelPrize recipient David Julius and @salkinstitute @Tcellogic. cell-symposia.com/neuroimmunolog…

Residency application season has officially begun. For those in leadership, remember to look for potential. We tend to tag trainees as "good" or "not good" and subsequently differentiate and project their career. Don't project a future; coach it.

#asthma is a combination of #eczema and #urticaria of the airway #COPD is #prurigo #nodularis of the airway

Atopic Dermatitis therapeutics are moving fast! Recent developments: - New IL13 on the market with lebrikizumab's FDA approval - Tralokinumab autoinjector now available, decreasing the number of injections by 50% These are all benefits for our patients.

Exciting to see innovation for diseases of older populations in dermatology. It’s about time. Efficacy and safety of low-dose Interleukin-2 in the treatment of moderate to severe bullous pemphigoid: jaad.org/article/S0190-…

@AllisonRBond Agree. Cutaneous dysesthesia Neuropathic dermatitis Dermatitis NOS These are what I use.

Delusional parasitosis very badly needs to be renamed ASAP

All credit for this project goes to @JayaManjunath1 and our Geriatric Dermatology ERG @AADskin Jaya is a 4th year and a world leader in Geriatric Dermatology. We hope this provides practical tips to approach tough conversations that NEED to happen. @TheDermEditor

Especially noteworthy since the two main authors come from @uazmedphx @UAZMedTucson where there is no PM&R program. Cudos to them for exploring this topic! @MilanOxspring @RileyBarnesMS #beardown

Curious what Derms think about these numbers.

3 out of every 10 USMD students applying to dermatology didn’t match. And this is a field where you need 15+ publications just to get an interview. Brutal.

When will JAK inhibitors replace steroids for short-term control of inflammatory disease? I imagine it's just an issue with access and cost? Thoughts?

Agree @DrJohnBarbieri is a special talent. Engaging and practical. A gift to the derm community.

Dr. John Barbeiri (@DrJohnBarbieri) has made significant contributions to dermatology, especially regarding the recent benzene issue. His efforts in engaging both experts and the public on this critical topic have been truly impactful. Let's honor his outstanding work by nominating him for the 'Member Making a Difference' award! aad.org/member/career/…" @AADmember @JAADjournals

IL-31 becomes an option. Exciting to have another target for so many pruritic patients with PN. galderma.com/news/galderma-…